Effect of Glucagon Receptor Antagonism on Ketogenesis in SGLT-2i Treated Subjects With T1D
Latest Information Update: 02 Aug 2023
At a glance
- Drugs Dapagliflozin (Primary) ; Volagidemab (Primary)
- Indications Type 1 diabetes mellitus
- Focus Pharmacodynamics; Therapeutic Use
- 26 Jun 2023 Primary endpoint has been met (Change in Glycemic Control) , according to Results presented at the 83rd Annual Scientific Sessions of the American Diabetes Association
- 26 Jun 2023 Primary endpoint has been met (Change in Beta-hydroxybutyrate (BHB) Level) , according to Results presented at the 83rd Annual Scientific Sessions of the American Diabetes Association
- 26 Jun 2023 Results presented at the 83rd Annual Scientific Sessions of the American Diabetes Association